These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20329433)

  • 1. Cerebrotendinous xanthomatosis: a treatable neurodegenerative disease.
    Sandeep P; Jayakrishnan C; Sadanan S; Sreekumar S; Thulasidharan NK
    J Assoc Physicians India; 2009 Oct; 57():716-7. PubMed ID: 20329433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inherited cholesterol lipidosis: cerebrotendinous xanthomatosis (van Bogaert Scherer Epstein disease). A clinicopathological study.
    Isenhardt K; Schmitt R; Nagel A; Drach L; Schlote W
    Clin Neuropathol; 2005; 24(6):276-83. PubMed ID: 16320823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrotendinous xanthomatosis in three siblings from a Chinese family.
    Ko KF; Lee KW
    Singapore Med J; 2001 Jan; 42(1):30-2. PubMed ID: 11361235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrotendinous xanthomatosis.
    Bel S; García-Patos V; Rodríguez L; Selva A; Díaz P; Wolthers BG; Castells A
    J Am Acad Dermatol; 2001 Aug; 45(2):292-5. PubMed ID: 11464194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic diarrhea and juvenile cataracts: think cerebrotendinous xanthomatosis and treat.
    Berginer VM; Gross B; Morad K; Kfir N; Morkos S; Aaref S; Falik-Zaccai TC
    Pediatrics; 2009 Jan; 123(1):143-7. PubMed ID: 19117873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visualisation of treatment response in a case of cerebrotendinous xanthomatosis.
    Seidel S; Kasprian G; Prayer D; Krssák M; Sycha T; Auff E
    J Neurol Neurosurg Psychiatry; 2011 Jun; 82(6):703-4. PubMed ID: 20660914
    [No Abstract]   [Full Text] [Related]  

  • 7. Cerebrotendinous xanthomatosis: a treatable ataxia.
    Clemen CS; Spottke EA; Lütjohann D; Urbach H; von Bergmann K; Klockgether T; Dodel R
    Neurology; 2005 Apr; 64(8):1476. PubMed ID: 15851751
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical reasoning: a case of treatable spastic paraparesis.
    McKinnon JH; Bosch EP
    Neurology; 2012 Aug; 79(6):e50-3. PubMed ID: 22869688
    [No Abstract]   [Full Text] [Related]  

  • 9. Cerebrotendinous xanthomatosis: a treatable cause of metabolic ataxia.
    Mukherjee AA; Chawla BP; Rathi SS; Puthran RS
    J Assoc Physicians India; 2007 Sep; 55():655-7. PubMed ID: 18051740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Teaching neuroimage: cerebrotendinous xanthomatosis.
    Mehta BP; Shmerling RH
    Neurology; 2008 Jul; 71(2):e4. PubMed ID: 18606959
    [No Abstract]   [Full Text] [Related]  

  • 11. Cerebrotendinous xanthomatosis (CTX): a treatable lipid storage disease.
    Keren Z; Falik-Zaccai TC
    Pediatr Endocrinol Rev; 2009 Sep; 7(1):6-11. PubMed ID: 19696711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrotendinous xanthomatosis.
    Federico A; Dotti MT
    Neurology; 2001 Nov; 57(9):1743. PubMed ID: 11706139
    [No Abstract]   [Full Text] [Related]  

  • 13. [Laboratory diagnosis of a rare congenital neurodegenerative disease: cerebrotendinous xanthomatosis].
    Varga VE; Katkó M; Harangi J; Balogh I; Kapás I; Madar L; Seres I; Molnár MJ; Paragh G; Kovács GG; Harangi M
    Orv Hetil; 2014 May; 155(21):811-6. PubMed ID: 24836315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cerebrotendinous xanthomatosis--a treatable metabolic disorder].
    Sperhake JP; Matschke J
    Nervenarzt; 2004 Jun; 75(6):608. PubMed ID: 15257383
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of MR imaging in the diagnosis of cerebrotendinous xanthogranulomatosis, case report and review of literature.
    Colonnese C; Bozzao A; Finocchi V; Iapaolo D; Fantozzi LM
    Radiol Med; 2003; 105(1-2):100-3. PubMed ID: 12700552
    [No Abstract]   [Full Text] [Related]  

  • 16. Cerebrotendinous xanthomatosis presenting as "chologenic diarrhoea".
    Bindl L; Lütjohann D; Lentze MJ; von Bergmann K
    Acta Paediatr; 2001 Jul; 90(7):828-9. PubMed ID: 11519995
    [No Abstract]   [Full Text] [Related]  

  • 17. Enlarging brain xanthomas in a patient with cerebrotendinous xanthomatosis.
    Brienza M; Fiermonte G; Cambieri C; Mignarri A; Dotti MT; Fiorelli M
    J Inherit Metab Dis; 2015 Sep; 38(5):981-2. PubMed ID: 25567502
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cerebrotendinous xanthomatosis: physiopathology, clinical manifestations and genetics].
    Preiss Y; Santos JL; Smalley SV; Maiz A
    Rev Med Chil; 2014 May; 142(5):616-22. PubMed ID: 25427019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cerebrotendinous xanthomatosis].
    Burghaus L; Liu W; Haupt WF
    Dtsch Med Wochenschr; 2007 Jul; 132(27):1463-6. PubMed ID: 17583829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain metabolism changes after therapy with chenodeoxycholic acid in a case of cerebrotendinous xanthomatosis.
    Caroppo P; D'Agata F; Mignarri A; Stromillo ML; Dotti MT; Mongini T
    Neurol Sci; 2013 Sep; 34(9):1693-6. PubMed ID: 23212406
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.